News
2 Sep 2021
OSE IMMUNOTHERAPEUTICS announces manufacturing agreement with CENEXI
OSE IMMUNOTHERAPEUTICS announces manufacturing agreement with CENEXI for clinical batches of covepit, OSE’s multi-target second-generation covid-19 vaccine
Mentioned Companies
PHIXEN
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance